U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 11 - 20 of 84

Commonly Used Drugs Charts

This NIDA web page includes information on commonly used drugs, including prescription drugs, with the potential for misuse or addiction.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

Community Safety Topic - Opioids

This overview of opioids from the NSC includes information on opioid misuse, recognizing signs of an overdose, prescription painkillers and chronic pain, and more.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Policymakers and Payers
First Responders
Source
National Safety Council (NSC)
Year
Resource Type
Web Page

Medications to Treat Opioid Use Disorder

This fact sheet includes basic descriptions of medications for opioid use disorders (MOUD) including naltrexone, buprenorphine, and methadone. It also addresses how MOUD can help those struggling with opioid use disorder, misunderstandings about MOUD, and additional considerations.
Format
Fact Sheet/Brochure
Audience
Patients
Families
Medical Providers
Other Team Members
Communities
Schools
Source
Partnership to End Addiction
Year
Resource Type
Web Page

Mitigating Risks from Human Xylazine Exposure

This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research.
Format
Webinar/Video
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Communities
Policymakers and Payers
States
Source
Regan-Udall Foundation for the FDA
Year
Resource Type
Web Page

Pain in the Nation 2023: The Epidemics of Alcohol, Drug, and Suicide Deaths

These recommendations from TFAH, primarily aimed at federal and state governments, aim to reduce alcohol, drug, and suicide deaths and to improve mental health and well-being for all Americans.
Format
Report/Paper/Issue Brief
Audience
States
Policymakers and Payers
Source
Trust for America's Mental Health (TFAH)
Year
Resource Type
PDF
File Size
1.7 MB

SAMHSA Training Requirements (MATE Act) Resources

This SAMHSA page includes information on 2023 training requirements that eliminated the DATA waiver that was previously needed to prescribe buprenorphine and expanded the number of DEA-registered practitioners able to treat people with opioid use disorder.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

The Role of Low-Threshold Treatment for Patients with Opioid Use Dusirder (OUD) in Primary Care

This Topic Brief provides an overview of what constitutes low-threshold treatment for patients with OUD, the state of the evidence and patient perspectives on low-threshold OUD treatment, and key steps and strategies for providing low-threshold treatment for patients with OUD in primary care settings.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Agency of Healthcare Quality and Research (AHRQ) Integration Academy
Year
Resource Type
Web Page